Novan, Inc.
(NASDAQ : NOVN)

( )
NOVN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -1.31%43.000.9%$1131.01m
ABBVAbbVie, Inc. -0.30%107.401.9%$1036.13m
JNJJohnson & Johnson -0.16%162.910.7%$988.77m
MRKMerck & Co., Inc. -0.11%73.280.7%$937.00m
LLYEli Lilly & Co. -2.07%221.721.1%$592.16m
BMYBristol-Myers Squibb Co. 0.02%59.851.0%$591.86m
AZNAstraZeneca Plc -1.86%57.631.0%$345.66m
NVSNovartis AG -0.34%82.310.2%$159.64m
CRVSCorvus Pharmaceuticals, Inc. -10.17%6.890.7%$147.73m
GSKGlaxoSmithKline Plc -1.14%38.060.2%$133.73m
RGENRepligen Corp. -7.09%285.576.8%$119.88m
RPRXRoyalty Pharma Plc -1.43%36.620.1%$118.91m
SNYSanofi -0.46%47.900.2%$117.35m
VTRSViatris, Inc. -0.87%13.700.0%$115.06m
APLSApellis Pharmaceuticals, Inc. 0.20%35.130.0%$104.57m

Company Profile

Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.